Home/Filings/4/0000950170-25-112659
4//SEC Filing

Keutzer Timothy 4

Accession 0000950170-25-112659

CIK 0001701108other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 6:02 AM ET

Size

5.0 KB

Accession

0000950170-25-112659

Insider Transaction Report

Form 4
Period: 2025-08-28
Keutzer Timothy
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2025-08-28$1.97/sh1,695$3,339739,744 total
Footnotes (1)
  • [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of restricted stock units ("RSUs") that were granted to the Reporting Person on August 26, 2021.

Documents

1 file

Issuer

Spero Therapeutics, Inc.

CIK 0001701108

Entity typeother

Related Parties

1
  • filerCIK 0001798155

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 6:02 AM ET
Size
5.0 KB